273 related articles for article (PubMed ID: 9683803)
21. Role of HGF/SF and c-Met in morphogenesis and metastasis of epithelial cells.
Birchmeier W; Brinkmann V; Niemann C; Meiners S; DiCesare S; Naundorf H; Sachs M
Ciba Found Symp; 1997; 212():230-40; discussion 240-6. PubMed ID: 9524774
[TBL] [Abstract][Full Text] [Related]
22. Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros.
Woolf AS; Kolatsi-Joannou M; Hardman P; Andermarcher E; Moorby C; Fine LG; Jat PS; Noble MD; Gherardi E
J Cell Biol; 1995 Jan; 128(1-2):171-84. PubMed ID: 7822413
[TBL] [Abstract][Full Text] [Related]
23. Scatter factor and angiogenesis.
Rosen EM; Goldberg ID
Adv Cancer Res; 1995; 67():257-79. PubMed ID: 8571817
[TBL] [Abstract][Full Text] [Related]
24. Met-HGF/SF: tumorigenesis, invasion and metastasis.
Vande Woude GF; Jeffers M; Cortner J; Alvord G; Tsarfaty I; Resau J
Ciba Found Symp; 1997; 212():119-30; discussion 130-2, 148-54. PubMed ID: 9524767
[TBL] [Abstract][Full Text] [Related]
25. Involvement of the hepatocyte growth factor/scatter factor receptor c-met and of Bcl-xL in the resistance of oropharyngeal cancer to ionizing radiation.
Aebersold DM; Kollar A; Beer KT; Laissue J; Greiner RH; Djonov V
Int J Cancer; 2001 Feb; 96(1):41-54. PubMed ID: 11241329
[TBL] [Abstract][Full Text] [Related]
26. HGF/SF in angiogenesis.
Rosen EM; Lamszus K; Laterra J; Polverini PJ; Rubin JS; Goldberg ID
Ciba Found Symp; 1997; 212():215-26; discussion 227-9. PubMed ID: 9524773
[TBL] [Abstract][Full Text] [Related]
27. HGF: a multifunctional growth factor controlling cell scattering.
Stella MC; Comoglio PM
Int J Biochem Cell Biol; 1999 Dec; 31(12):1357-62. PubMed ID: 10641789
[TBL] [Abstract][Full Text] [Related]
28. c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination.
Taher TE; Tjin EP; Beuling EA; Borst J; Spaargaren M; Pals ST
J Immunol; 2002 Oct; 169(7):3793-800. PubMed ID: 12244174
[TBL] [Abstract][Full Text] [Related]
29. Epigallocatechin-3-gallate inhibits paracrine and autocrine hepatocyte growth factor/scatter factor-induced tumor cell migration and invasion.
Kwak IH; Shin YH; Kim M; Cha HY; Nam HJ; Lee BS; Chaudhary SC; Pai KS; Lee JH
Exp Mol Med; 2011 Feb; 43(2):111-20. PubMed ID: 21209554
[TBL] [Abstract][Full Text] [Related]
30. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells.
Jeffers M; Rong S; Anver M; Vande Woude GF
Oncogene; 1996 Aug; 13(4):853-6. PubMed ID: 8761307
[TBL] [Abstract][Full Text] [Related]
31. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
Webb CP; Hose CD; Koochekpour S; Jeffers M; Oskarsson M; Sausville E; Monks A; Vande Woude GF
Cancer Res; 2000 Jan; 60(2):342-9. PubMed ID: 10667586
[TBL] [Abstract][Full Text] [Related]
32. Absence of mutations in the kinase domain of the Met gene and frequent expression of Met and HGF/SF protein in primary gastric carcinomas.
Park WS; Oh RR; Kim YS; Park JY; Shin MS; Lee HK; Lee SH; Yoo NJ; Lee JY
APMIS; 2000 Mar; 108(3):195-200. PubMed ID: 10752688
[TBL] [Abstract][Full Text] [Related]
33. Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition.
Maulik G; Shrikhande A; Kijima T; Ma PC; Morrison PT; Salgia R
Cytokine Growth Factor Rev; 2002 Feb; 13(1):41-59. PubMed ID: 11750879
[TBL] [Abstract][Full Text] [Related]
34. Hepatocyte growth factor expression in human cancer and therapy with specific inhibitors.
Haddad R; Lipson KE; Webb CP
Anticancer Res; 2001; 21(6B):4243-52. PubMed ID: 11908677
[TBL] [Abstract][Full Text] [Related]
35. The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells.
Weidner KM; Sachs M; Birchmeier W
J Cell Biol; 1993 Apr; 121(1):145-54. PubMed ID: 8384622
[TBL] [Abstract][Full Text] [Related]
36. Tyrosine 1356 in the carboxyl-terminal tail of the HGF/SF receptor is essential for the transduction of signals for cell motility and morphogenesis.
Zhu H; Naujokas MA; Fixman ED; Torossian K; Park M
J Biol Chem; 1994 Nov; 269(47):29943-8. PubMed ID: 7961992
[TBL] [Abstract][Full Text] [Related]
37. Met and hepatocyte growth factor/scatter factor expression in human gliomas.
Koochekpour S; Jeffers M; Rulong S; Taylor G; Klineberg E; Hudson EA; Resau JH; Vande Woude GF
Cancer Res; 1997 Dec; 57(23):5391-8. PubMed ID: 9393765
[TBL] [Abstract][Full Text] [Related]
38. SF/HGF-c-Met autocrine and paracrine promote metastasis of hepatocellular carcinoma.
Xie Q; Liu KD; Hu MY; Zhou K
World J Gastroenterol; 2001 Dec; 7(6):816-20. PubMed ID: 11854908
[TBL] [Abstract][Full Text] [Related]
39. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression.
Abounader R; Ranganathan S; Lal B; Fielding K; Book A; Dietz H; Burger P; Laterra J
J Natl Cancer Inst; 1999 Sep; 91(18):1548-56. PubMed ID: 10491431
[TBL] [Abstract][Full Text] [Related]
40. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase.
Birchmeier C; Gherardi E
Trends Cell Biol; 1998 Oct; 8(10):404-10. PubMed ID: 9789329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
